Dr. McFadden is a Professor in the Department of Molecular Genetics and Microbiology at the University of Florida. He received a B.Sc. degree (Honours Biochemistry) in 1970 and a Ph.D. degree (Biochemistry) in 1975, both from McGill University in Montreal, Canada. In 2001, he was named Canada Research Chair in Molecular Virology and, in 2002, he received the Hellmuth Prize. He was inducted as a Fellow of the Royal Society of Canada in 2004 and as a Fellow of the American Academy of Microbiology in 2007. In 1997, Dr. McFadden co-founded Viron Therapeutics, Inc. (with Dr. A. Lucas) in London, Ontario to explore the use of viral proteins for therapeutic purposes against inflammatory diseases. He continues to expand the portfolio of viral immune modulating agents that can be derived from the large DNA viruses and current understanding of viral pathogenesis together with immune and inflammation based mechanisms of disease.